Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Chemtura Makes Portfolio Moves
March 10, 2008
| A version of this story appeared in
Volume 86, Issue 10
Chemtura has acquired a 46.5% stake in Baxenden Chemicals from partner Croda for $26 million. The transaction will give Chemtura full ownership of the polyurethanes specialist, which has annual sales of $70 million and employs 212 people in Accrington and Droitwich, England. Chemtura says the integration will broaden its polyurethanes portfolio. Separately, Chemtura has completed the sale of its oleochemicals business, with 260 employees and sales of $175 million, to PMC Group for an undisclosed price. In December, Chemtura hired Merrill Lynch to help it assess strategic options, including a possible sale of the entire firm.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X